| Literature DB >> 27242522 |
Lara Ianov1, Asha Rani2, Blanca S Beas2, Ashok Kumar2, Thomas C Foster1.
Abstract
Cognitive function depends on transcription; however, there is little information linking altered gene expression to impaired prefrontal cortex function during aging. Young and aged F344 rats were characterized on attentional set shift and spatial memory tasks. Transcriptional differences associated with age and cognition were examined using RNA sequencing to construct transcriptomic profiles for the medial prefrontal cortex (mPFC), white matter, and region CA1 of the hippocampus. The results indicate regional differences in vulnerability to aging. Age-related gene expression in the mPFC was similar to, though less robust than, changes in the dorsolateral PFC of aging humans suggesting that aging processes may be similar. Importantly, the pattern of transcription associated with aging did not predict cognitive decline. Rather, increased mPFC expression of genes involved in regulation of transcription, including transcription factors that regulate the strength of excitatory and inhibitory inputs, and neural activity-related immediate-early genes was observed in aged animals that exhibit delayed set shift behavior. The specificity of impairment on a mPFC-dependent task, associated with a particular mPFC transcriptional profile indicates that impaired executive function involves altered transcriptional regulation and neural activity/plasticity processes that are distinct from that described for impaired hippocampal function.Entities:
Keywords: aging; cognitive flexibility; prefrontal cortex; set shifting task; transcription
Year: 2016 PMID: 27242522 PMCID: PMC4868850 DOI: 10.3389/fnagi.2016.00113
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Figure 1Region of the mPFC and white matter (WM) collected for RNA-seq. The right panel provides a schematic of a coronal slice +2.7 anterior to bregma diagram as adapted from Paxinos and Watson (1986) and illustrates the region of the mPFC and white matter collected for RNA-seq. The left panel shows a coronal slice from this same region.
Figure 2Performance on the visual discrimination and set shift operant tasks. Trials to criteria (TTC) are illustrated for individual aged (filled circles, n = 20) and young (open circles, n = 11) animals during performance of the (A) initial visual discrimination and (B) set shift tasks. Asterisk indicates that aged animals exhibited more trails to criteria for the set shift task (p < 0.01). The open bars indicate the mean TTC for each group.
Figure 3Performance on the water maze task. Symbols indicate the mean (±SEM) escape path length to the escape platform during five training blocks on the (A) cue and (B) spatial discrimination tasks for young (open symbols) and aged (filled symbols) animals. Individual (C) platform crossing and (D) discrimination index scores for young (open symbols) and aged (filled symbols) animals. The open bars indicate the means for each group.
Behavioral correlations.
| Set shift TTC | 0.168 | 0.115 | −0.356 | 0.145 | 0.154 |
| Visual TTC | 0.245 | −0.185 | 0.197 | 0.309 | |
| Cue block 5 | 0.29 | −0.126 | 0.17 | ||
| Spatial block 5 | −0.376 | −0.484 | |||
| Crossings | 0.311 |
p < 0.05.
Figure 4Number of genes altered during aging across regions. Graphic summary of the total number of genes whose expression either significantly (p < 0.025) increased (up arrow) or decreased (down arrow) in the mPFC, region CA1, white matter, and across regions.
Age-related changes across the rat mPFC and the dorsolateral PFC of humans.
| Acidic leucine-rich nuclear phosphoprotein 32 family member B | Increased | |
| Complement component 4A | Increased | |
| Chitinase 3-like 1 (cartilage glycoprotein-39) | Increased | |
| Clusterin | Increased | |
| Disheveled associated activator of morphogenesis 2 | Increased | |
| Enabled homolog | Increased | |
| Fibroblast growth factor receptor 1 | Increased | |
| Glial fibrillary acidic protein | Increased | |
| Homeodomain interacting protein kinase 2 | Increased | |
| Monoamine oxidase B | Increased | |
| Microtubule-associated protein 4 | Increased | |
| Microtubule-associated protein 7 | Increased | |
| MID1 interacting protein 1 | Increased | |
| Monooxygenase, DBH-like 1 | Increased | |
| MAX interactor 1 | Increased | |
| Pleckstrin homology domain containing, family B (evectins) member 1 | Increased | |
| PTK2B protein tyrosine kinase 2 beta | Increased | |
| Ras association (RalGDS/AF-6) domain family member 2 | Increased | |
| Sperm specific antigen 2 | Increased | |
| Unc-84 homolog B ( | Increased | |
| Zinc finger, CCHC domain containing 24 | Increased | |
| ADAM metallopeptidase with thrombospondin type 1 motif, 8 | Decreased | |
| ArfGAP with FG repeats 1 | Decreased | |
| Calcium channel, voltage-dependent, T type, alpha 1G subunit | Decreased | |
| Calcium/calmodulin-dependent serine protein kinase (MAGUK family) | Decreased | |
| Cadherin 11, type 2, OB-cadherin (osteoblast) | Decreased | |
| Cadherin 8, type 2 | Decreased | |
| Cyclin-dependent kinase 5 | Decreased | |
| Corticotropin releasing hormone | Decreased | |
| Corticotropin releasing hormone receptor 1 | Decreased | |
| Chemokine (C-X3-C motif) ligand 1 | Decreased | |
| Cytochrome P450, family 26, subfamily B, polypeptide 1 | Decreased | |
| WD repeat domain 68 | Decreased | |
| DnaJ (Hsp40) homolog, subfamily B, member 5 | Decreased | |
| Dual specificity phosphatase 14 | Decreased | |
| Endothelin 3 | Decreased | |
| Early growth response 4 | Decreased | |
| Eukaryotic translation initiation factor 4 gamma, 1 | Decreased | |
| Family with sequence similarity 131, member A | Decreased | |
| Family with sequence similarity 49, member A | Decreased | |
| Gamma-aminobutyric acid (GABA) A receptor, alpha 4 | Decreased | |
| Guanine nucleotide binding protein (G protein), gamma 4 | Decreased | |
| Glutamate receptor, metabotropic 2 | Decreased | |
| 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 | Decreased | |
| 5-hydroxytryptamine (serotonin) receptor 2A | Decreased | |
| Potassium voltage-gated channel, subfamily F, member 1 | Decreased | |
| Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Decreased | |
| LanC lantibiotic synthetase component C-like 2 (bacterial) | Decreased | |
| Like-glycosyltransferase | Decreased | |
| Plasticity related gene 1 | Decreased | |
| Mitogen-activated protein kinase 4 | Decreased | |
| Monocyte to macrophage differentiation-associated | Decreased | |
| Neuropilin (NRP) and tolloid (TLL)-like 2 | Decreased | |
| Reprimo, TP53 dependent G2 arrest mediator candidate | Decreased | |
| KIAA0746 protein | Decreased | |
| Solute carrier family 8 (sodium/calcium exchanger), member 2 | Decreased | |
| Somatostatin | Decreased | |
| Somatostatin receptor 1 | Decreased | |
| ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 | Decreased | |
| Tribbles homolog 2 | Decreased |
Increased mPFC expression during aging.
| ADAM metallopeptidase domain 17 | X | X | ||
| Fc fragment of IgG, low affinity IIb, receptor (CD32) | X | X | ||
| POU class 2 homeobox 3 | X | |||
| RAB27A, member RAS oncogene family | X | X | ||
| TIMP metallopeptidase inhibitor 3 | X | |||
| Bone morphogenetic protein 6 | X | |||
| Cathepsin B | X | |||
| Clusterin | X | |||
| Coagulation factor XI | X | |||
| Complement component 1, q subcomponent, C chain | X | X | ||
| Complement component 1, q subcomponent | X | X | ||
| Complement component 4B | X | X | ||
| Fibronectin 1 | X | |||
| Glial fibrillary acidic protein | X | |||
| Heme oxygenase (decycling) 1 | X | X | ||
| Integrin beta 2 | X | |||
| Neutrophil cytosolic factor 1 | X | |||
| Platelet/endothelial cell adhesion molecule 1 | X | |||
| Podoplanin | X | |||
| Secreted protein, acidic, cysteine-rich | X | |||
| Serpin peptidase inhibitor, clade A | X | |||
| Triggering receptor expressed on myeloid cells-like 1 | X | |||
| Tumor protein p73 | X | |||
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 | X | |||
| SWAP-70 protein | X | |||
| Interleukin 18 | X | |||
| Interleukin 18 binding protein | X | |||
| Leukocyte immunoglobulin-like receptor | X | |||
| 4-hydroxyphenylpyruvate dioxygenase | X | |||
| Acyl-Coenzyme A dehydrogenase | X | |||
| Acyl-Coenzyme A dehydrogenase, long-chain | X | |||
| Alcohol dehydrogenase, iron containing, 1 | X | |||
| Aldehyde dehydrogenase 1 family | X | |||
| Aldehyde dehydrogenase 2 family | X | |||
| Aldehyde dehydrogenase 6 family, member A1 | X | |||
| Aldo-keto reductase family 1, member C13 | X | |||
| Aminoadipate-semialdehyde synthase | X | |||
| Apoptosis-inducing factor | X | |||
| Cysteine dioxygenase, type I | X | |||
| Cytochrome b reductase 1 | X | |||
| Dicarbonyl L-xylulose reductase | X | |||
| Flavin containing monooxygenase 2 | X | |||
| Hydroxyacyl-Coenzyme A dehydrogenase | X | |||
| Hydroxyacyl-Coenzyme A dehydrogenase | X | |||
| Hydroxysteroid (17-beta) dehydrogenase 4 | X | |||
| Isocitrate dehydrogenase 2 (NADP+) | X | |||
| Monoamine oxidase B | X | |||
| Acyl-Coenzyme A dehydrogenase family | X | |||
| Phytanoyl-CoA dioxygenase domain containing 1 | X | |||
| Procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 | X | |||
| Pyridine nucleotide-disulphide oxidoreductase domain 2 | X | |||
| Phosphoglycerate dehydrogenase | X | |||
| Proline dehydrogenase | X | |||
| Solute carrier family 14 (urea transporter) | X | |||
| Thromboxane A synthase 1, platelet | X | |||
| Tryptophan hydroxylase 1 | X | |||
| Xanthine dehydrogenase | X |
Figure 5Heat map of age-related changes in gene expression for the mPFC. Each row represents a differentially expressed gene (p < 0.025) associated with aging. Expression for each gene was converted to a standardized score and the color represents the standard deviation increasing (red) or decreasing (blue) relative to the mean (gray). The age-related gene enrichment clusters are indicated (FDR p < 0.05). Top clusters: Genes that exhibit a decrease from young (left) to aged (right) animals. Bottom: Genes that exhibit an increase from young to aged animals.
Decreased mPFC expression during aging.
| Ankyrin repeat and sterile alpha motif domain containing 1B | X | X | X | |
| Calsyntenin 3 | X | X | ||
| Cerebellin 1 precursor | X | |||
| Cholinergic receptor, muscarinic 2 | X | X | X | |
| Cholinergic receptor, nicotinic, alpha 5 | X | X | X | |
| Cytochrome P450, family 19, subfamily a, polypeptide 1 | X | X | ||
| Double C2-like domains, alpha | X | |||
| Dynamin 3 | X | X | ||
| Gamma-aminobutyric acid (GABA) A receptor, alpha 4 | X | X | ||
| Glutamate decarboxylase 1 | X | X | ||
| Glutamate receptor interacting protein 1 | X | X | ||
| Glutamate receptor, ionotropic, delta 1 | X | X | ||
| Glutamate receptor, ionotropic, delta 2 | X | X | ||
| Glutamate receptor, ionotropic, kainate 3 | X | X | X | |
| Glutamate receptor, metabotropic 7 | X | X | X | |
| Glutamate receptor, metabotropic 8 | X | X | X | |
| Glycine receptor, beta | X | X | ||
| Lin-7 homolog b ( | X | X | ||
| Melanoma antigen, family E, 1 | X | X | X | |
| Secretory carrier membrane protein 1 | X | |||
| Similar to CG2662-PA; protein kinase, cAMP-dependent, catalytic, alpha | X | |||
| Solute carrier family 2 (facilitated glucose transporter), member 3 | X | |||
| Synaptic vesicle glycoprotein 2b | X | |||
| Synaptotagmin VI | X | |||
| Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | X | |||
| Beta-site APP cleaving enzyme 1 | X | |||
| Deleted in colorectal carcinoma | X | |||
| Dihydropyrimidinase-like 2 | X | |||
| Dihydropyrimidinase-like 5 | X | |||
| Dynactin 2 | X | |||
| Glutamic-oxaloacetic transaminase 1 | X | |||
| Kelch-like 1 (Drosophila) | X | |||
| Mitogen activated protein kinase kinase 4 | X | |||
| Potassium inwardly-rectifying channel | X | |||
| Progesterone receptor | X | |||
| Protein tyrosine phosphatase | X | |||
| Tachykinin receptor 3 | X |
Figure 6Number of genes correlated with behavioral measures. Graphic summary for the number of mPFC genes whose expression either significantly increased (filled) or decreased (open) in relation to performance on the set shift and visual discrimination operant tasks, and a spatial memory task (Pearson's correlation p < 0.025). A large number of genes exhibited increased expression associated with impaired set shifting compared to visual discrimination and spatial discrimination index (DI).
Positive correlation of mPFC genes with set shift TTC.
| B-cell CLL/lymphoma 6, member B | X | |||
| BCL6 co-repressor | X | |||
| CCAAT/enhancer binding protein (C/EBP), beta | X | |||
| CCAAT/enhancer binding protein (C/EBP), delta | X | X | ||
| DnaJ (Hsp40) homolog, subfamily B, member 5 | X | X | ||
| FBJ osteosarcoma oncogene | X | X | ||
| FBJ osteosarcoma oncogene B | X | X | ||
| Jun oncogene | X | X | X | |
| Max dimerization protein 3 | X | |||
| Meis homeobox 1 | X | |||
| Ngfi-A binding protein 2 | X | |||
| Swi/SNF related matrix associated | X | |||
| TSC22 domain family, member 3 | X | X | ||
| Coiled-coil domain containing 101 | X | |||
| Cryptochrome 2 (photolyase-like) | X | |||
| Cysteine-serine-rich nuclear protein 1 | X | |||
| Distal-less homeobox 1 | X | X | ||
| Early growth response 1 | X | X | ||
| Early growth response 2 | X | X | ||
| Early growth response 3 | X | |||
| Early growth response 4 | X | |||
| Fos-like antigen 2 | X | X | ||
| Hairy and enhancer of split 3 (Drosophila) | X | |||
| Heme oxygenase (decycling) 1 | X | X | X | |
| Inhibitor of growth family, member 3 | X | X | ||
| Integrin alpha 9; eomesodermin homolog | X | |||
| Jumonji domain containing 3 | X | |||
| Jumonji domain containing 6 | X | |||
| Jun B proto-oncogene | X | X | ||
| Max binding protein | X | X | ||
| Myocyte enhancer factor 2B | X | |||
| Neuronal PAS domain protein 1 | X | |||
| Neuronal PAS domain protein 4 | X | |||
| Nuclear factor of kappa light polypeptide gene enhancer | X | X | X | |
| Nuclear receptor subfamily 4, group A, member 1 | X | X | ||
| Nuclear receptor subfamily 4, group A, member 2 | X | X | X | |
| Paired box 1 | X | |||
| Period homolog 1 (Drosophila) | X | |||
| Retinoid X receptor alpha | X | X | X | |
| Serum response factor (c-fos transcription factor) | X | X | ||
| Single-minded homolog 2 | X | |||
| Timeless homolog | X | |||
| Transducin-like enhancer of split 3 | X | |||
| Tribbles homolog 1 | X | X | ||
| v-maf musculoaponeurotic fibrosarcoma oncogene | X | |||
| v-myc myelocytomatosis viral related oncogene | X | |||
| CUB and zona pellucida-like domains 1 | X | |||
| RAS-like, estrogen-regulated, growth-inhibitor | X | |||
| Apolipoprotein B (including Ag(x) antigen) | X | |||
| Carboxypeptidase N, polypeptide 1 | X | |||
| Cyclin-dependent kinase inhibitor 1A | X | X | ||
| Deleted in liver cancer 1 | X | X | ||
| Dual specificity phosphatase 4 | X | |||
| Guanine nucleotide binding protein (G protein), gamma 7 | X | |||
| Heat shock 70 kD protein 1B, 1A | X | X | ||
| Hydroxysteroid 11-beta dehydrogenase 2 | X | |||
| Insulin receptor substrate 2 | X | |||
| Large tumor suppressor 2 | X | |||
| Plasminogen activator, tissue | X | |||
| Potassium voltage-gated channel, member 5 | X | |||
| Protein phosphatase 5, catalytic subunit | X | |||
| Solute carrier family 6, member 3 | X | |||
| Sphingosine kinase 1 | X | X | ||
| Steroid sulfatase | X | |||
| Suppressor of cytokine signaling 3 | X | |||
| Vesicle-associated membrane protein 2 | X | |||
| BRCA1 associated RING domain 1 | X | |||
| Bcl2-associated athanogene 3 | X | |||
| GDNF family receptor alpha like | X | |||
| NUAK family, SNF1-like kinase, 2 | X | |||
| Apoptosis-inducing factor, mitochondrion-associated 3 | X | |||
| Cell death-inducing DNA fragmentation factor | X | |||
| Complement component 5 | X | |||
| Glutamate receptor, metabotropic 4 | X | |||
| Pim-1 oncogene | X | |||
| Pleckstrin homology domain containing, family F | X | |||
| Serine incorporator 3 | X | |||
| Lymphocyte-specific protein tyrosine kinase | X |
Figure 7Impaired set shifting is associated with increased expression of genes involved in transcription regulation. The z-scores for the cluster of 46 transcription regulation genes were averaged for each animal. Individual mean z-scores (y-axes) are plotted relative to z-scores for set shift TTC (x-axes). The correlation is illustrated as a regression line (dashed line).
Increased expression in the mPFC for AI vs. AU.
| Activity regulated cytoskeletal-associated protein | 1.89 | −1.19 | |
| Basic helix-loop-helix domain containing, class B2 | 1.22 | −1.08 | |
| B-cell translocation gene 2, anti-proliferative | 1.49 | −1.28 | |
| Dual specificity phosphatase 1 | 1.45 | −1.27 | |
| Early growth response 1 | 1.57 | −1.31 | |
| Early growth response 2 | 2.79 | −1.37 | |
| Early growth response 4 | 1.53 | −1.41 | |
| Heat shock 70 kD protein 1A | 2.12 | −1.26 | |
| Heat shock 70 kD protein 1B | 1.84 | −1.46 | |
| Immediate early response 5 | 1.29 | −1.17 | |
| Jun-B oncogene | 1.50 | −1.36 | |
| Krueppel-like factor 10 | 1.36 | −1.29 | |
| Nuclear receptor subfamily 4, group A, member 1 | 1.60 | −1.23 | |
| Nuclear receptor subfamily 4, group A, member 3 | 1.39 | −1.20 | |
| Prostaglandin-endoperoxide synthase 2 | 1.36 | −1.12 | |
| SNF1-like kinase | 1.76 | −1.12 |
Figure 8Set shifting performance for animals used in RT-qPCR validations. The animals were selected based on set shifting performance to insure group differences in behavior. The bars illustrate this difference as the mean + SEM TTC for young (n = 9) and aged animals classified as unimpaired (AU, n = 6) and impaired (AI, n = 6) on the set shift task. Asterisks indicate a significant (p < 0.05) difference relative to AI animals.
Figure 9Comparison between RT-qPCR and RNA-seq. Six genes were selected for validation experiments using a subset of animals. Each panel provides the mPFC expression determined by RT-qPCR (left, ΔΔCT values) and RNA-seq (right, counts). Two-tailed t-tests confirmed increased expression of Arc, Fos, Egr1, Egr2, and Egr4 in AI, relative to AU rats. Gene expression for young animals is provided for comparison to aged animals. For two genes, Lin7b and Egr4, age differences were confirmed (***p < 0.005, **p < 0.025, *p < 0.05).